Rajesh Chopra

Rajesh Chopra

Chief Executive Officer at Aethon Therapeutics, Inc.

63 year
Health Technology
Consumer Services
Miscellaneous

Profile

Rajesh Chopra is currently the Chief Executive Officer & Director at Aethon Therapeutics, Inc. He is also a Non-Executive Director at Artios Pharma Ltd., a Director at Nereid Therapeutics, Inc., and a Venture Partner at Apple Tree Venture Management Llc.
In the past, he worked as a Director-Medical Science at AstraZeneca PLC from 2004 to 2009, an Independent Non-Executive Director at e-Therapeutics Plc from 2012 to 2015, and as the VP-Translational & Early Drug Development at Celgene Corp.
from 2009 to 2016.
He also served as the Director-Hematological Oncology Department at The Christie NHS Foundation Trust.
Dr. Chopra holds a doctorate degree from University College London and an undergraduate degree from The UCL Academy.

Rajesh Chopra active positions

CompaniesPositionStart
Director/Board Member 2019-02-10
Private Equity Investor 2021-10-20
Director/Board Member -
Chief Executive Officer -
All active positions of Rajesh Chopra

Former positions of Rajesh Chopra

CompaniesPositionEnd
CELGENE Corporate Officer/Principal 2015-12-31
E-THERAPEUTICS PLC Director/Board Member 2015-10-28
ASTRAZENECA PLC Corporate Officer/Principal 2009-03-31
The Christie NHS Foundation Trust Corporate Officer/Principal -
See the detail of Rajesh Chopra's experience

Training of Rajesh Chopra

University College London Doctorate Degree
The UCL Academy Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rajesh Chopra's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
E-THERAPEUTICS PLC

Health Technology

ASTRAZENECA PLC

Health Technology

Private companies6

Health Technology

The Christie NHS Foundation Trust

Miscellaneous

Health Technology

Finance

Health Technology

Health Services

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW